Serine protease inhibitors and cytotoxic T lymphocytes.
Serine proteases control a wide variety of physiological and pathological processes in multi-cellular organisms, including blood clotting, cancer, cell death, osmoregulation, tissue remodeling, and immunity to infection. Cytotoxic T lymphocytes (CTLs) are required for adaptive cell-mediated immunity to intracellular pathogens by killing infected cells and through the development of memory T cells. Serine proteases not only allow a CTL to kill but also impose homeostatic control on CTL number. Serine protease inhibitors (serpins) are the physiological regulators of serine proteases' activity. In this review, I discuss the role of serpins in controlling the recognition of antigen, effector function, and homeostatic control of CTLs through the inhibition of physiological serine protease targets. An emerging view of serpins is that they are important promoters of cellular viability through their inhibition of executioner proteases. This view is discussed in the context of the T-lymphocyte survival during effector responses and the development and persistence of long-lived memory T cells. Given the important role serpins play in CTL immunity, I discuss the potential for developing new immunotherapeutic approaches based directly on serpins or knowledge gained from identifying their physiologically relevant protease targets.
Department of Immunology, Faculty of Medicine, Imperial College London, London W12 0NN, UK. p.ashton-rickardt@imperial.ac.uk
Philip G
PG
Ashton-Rickardt
D000818:Animals; D017209:Apoptosis; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007156:Immunologic Memory; D007167:Immunotherapy / Q000379:methods; D057057:Serine Proteases / Q000276:immunology / Q000378:metabolism*; D015843:Serpins / Q000276:immunology / Q000378:metabolism* / Q000627:therapeutic use; D013602:T-Lymphocytes, Cytotoxic / Q000201:enzymology* / Q000276:immunology
D015843:Serpins; D057057:Serine Proteases